Three bioactive compounds from Huangqin decoction ameliorate Irinotecan-induced diarrhea via dual-targeting of Escherichia coli and bacterial β-glucuronidase
Open Access
- 18 October 2024
- journal article
- research article
- Published by Springer Nature in Cell Biology and Toxicology
- Vol. 40 (1) , 1-28
Abstract
Irinotecan (CPT-11) is a commonly prescribed chemotherapeutic for the treatment of colon cancer. Unfortunately, acute and delayed diarrhea are prominent side effects of CPT-11 use, and this limits its therapeutic potential. The curative effect of Huangqin decoction (HQD) on chemotherapy-induced diarrhea has been proven. This study investigated the efficacy of the components of HQD (baicalein, baicalin, and paeoniflorin) on CPT-11-induced diarrhea and their underlying mechanisms. Baicalein was found to be the most effective component in improving CPT-11-induced enterotoxicity by intestinal permeability test, ELISA, fluorescence co-localization, and IHC. The combination of baicalin, baicalin and paeoniflorin can obtain similar therapeutic effect to that of HQD. Mendelian randomization analysis, 16 s rRNA sequencing, and fluorescence imaging revealed that baicalein and baicalin significantly inhibited β-glucuronidase (β-GUS) activity. Bacterial abundance analysis and scanning electron microscopy showed that baicalein inhibited the proliferation of Escherichia coli by destroying its cell wall. The molecular dynamics and site-directed mutagenesis results revealed the structural basis for the inhibition of β-GUS by baicalein and baicalin. The results above provide a new idea for the development of drug therapy for adjuvant chemotherapy and theoretical guidance for the optimization of molecular structure targeting β-GUS. Graphical AbstractKeywords
This publication has 55 references indexed in Scilit:
- Huangqin Decoction Delays Progress of Colitis-Associated Carcinogenesis by Regulating Nrf2/HO-1 Antioxidant Signal Pathway in MiceChinese Journal of Integrative Medicine, 2023
- Biotransformation to synthesize the methylated derivatives of baicalein using engineered Escherichia coliBioprocess and Biosystems Engineering, 2023
- Loperamide Cardiac Toxicity: Pathophysiology, Presentation, and ManagementCanadian Journal of Cardiology, 2022
- Protective effect of baicalin on the regulation of Treg/Th17 balance, gut microbiota and short-chain fatty acids in rats with ulcerative colitisApplied Microbiology and Biotechnology, 2020
- Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and PharmacogeneticsClinical Pharmacokinetics, 2018
- Clinical Review: Loperamide ToxicityAnnals of Emergency Medicine, 2017
- Baicalein exhibits anti-inflammatory effects via inhibition of NF-κB transactivationBiochemical Pharmacology, 2016
- Multiwfn: A multifunctional wavefunction analyzerJournal of Computational Chemistry, 2011
- Identification of chemicals and their metabolites from PHY906, a Chinese medicine formulation, in the plasma of a patient treated with irinotecan and PHY906 using liquid chromatography/tandem mass spectrometry (LC/MS/MS)Journal of Chromatography A, 2010
- GROMACS: Fast, flexible, and freeJournal of Computational Chemistry, 2005